Compare Onto Innovation (ONTO) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Onto Innovation vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Onto Innovation trades at $294.2 (market cap $14.36B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.88 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is the larger of the two by market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Onto Innovation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Onto Innovation for 6 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| ONTO | RPRX | |
|---|---|---|
Market Cap | $14.36B | $25.27B |
Volume | 761,617 | 3,671,183 |
Sector | Technology | Health |
52-Week High | $378.45 | $63.96 |
52-Week Low | $121.34 | $35.44 |
Typical Hold Time | 6 Days | 1 Days |
Enterprise Value | $13.95B | $32.50B |
Dividend Yield | — | 1.66% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Onto Innovation
Onto Innovation provides process control solutions for semiconductor manufacturing. Its inspection and metrology systems help chipmakers measure, analyze, and detect defects on wafers and advanced packages.
Read more on ONTO →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
